Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics
Open Access
- 23 January 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (2), e21329
- https://doi.org/10.1096/fj.202002163r
Abstract
L1 syndrome is a rare developmental disorder characterized by hydrocephalus of varying severity, intellectual deficits, spasticity of the legs, and adducted thumbs. Therapy is limited to symptomatic relief. Numerous gene mutations in the L1 cell adhesion molecule (L1CAM, hereafter abbreviated L1) were identified in L1 syndrome patients, and those affecting the extracellular domain of this transmembrane type 1 glycoprotein show the most severe phenotypes. Previously analyzed rodent models of the L1 syndrome focused on L1‐deficient animals or mouse mutants with abrogated cell surface expression of L1, making it difficult to test L1 function‐triggering mimetic compounds with potential therapeutic value. To overcome this impasse, we generated a novel L1 syndrome mouse with a mutation of aspartic acid at position 201 in the extracellular part of L1 (p.D201N, hereafter termed L1‐201) that displays a cell surface‐exposed L1 accessible to the L1 mimetics. Behavioral assessment revealed an increased neurological deficit score and increased locomotor activity in male L1‐201 mice carrying the mutation on the X‐chromosome. Histological analyses of L1‐201 mice showed features of the L1 syndrome, including enlarged ventricles and reduced size of the corpus callosum. Expression levels of L1‐201 protein as well as extent of cell surface biotinylation and immunofluorescence labelling of cultured cerebellar neurons were normal. Importantly, treatment of these cultures with the L1 mimetic compounds duloxetine, crotamiton, and trimebutine rescued impaired cell migration and survival as well as neuritogenesis. Altogether, the novel L1 syndrome mouse model provides a first experimental proof‐of‐principle for the potential therapeutic value of L1 mimetic compounds.Keywords
This publication has 46 references indexed in Scilit:
- Homophilic interaction of the L1 family of cell adhesion moleculesExperimental & Molecular Medicine, 2012
- Polysialic Acid Glycomimetic Promotes Functional Recovery and Plasticity After Spinal Cord Injury in MiceMolecular Therapy, 2010
- A modifier locus on chromosome 5 contributes to L1 cell adhesion molecule X-linked hydrocephalus in miceneurogenetics, 2009
- Extracellular GAPDH binds to L1 and enhances neurite outgrowthMolecular and Cellular Neuroscience, 2009
- Cryo-Electron Tomography of Homophilic Adhesion Mediated by the Neural Cell Adhesion Molecule L1Structure, 2009
- Molecular mechanisms and neuroimaging criteria for severe L1 syndrome with X-linked hydrocephalusJournal of Neurosurgery: Pediatrics, 2006
- Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesisJournal of Neurochemistry, 2005
- Structural Analysis of the Murine Cell Adhesion Molecule L1 by Electron Microscopy and Computer‐assisted ModellingEuropean Journal of Neuroscience, 1996
- Identification of the border between fibronectin type III homologous repeats 2 and 3 of the neural cell adhesion molecule L1 as a neurite outgrowth promoting and signal transducing domainJournal of Neurobiology, 1995
- Restricted localization of L1 and N‐CAM at sites of contact between Schwann cells and neurites in cultureGlia, 1994